Cargando…
Bilateral Anterior Subcapsular Cataract Development Following Initiation of Enfortumab Vedotin
Enfortumab vedotin is an antibody–drug conjugate that was recently granted accelerated US Food and Drug Administration approval for the treatment of locally advanced or metastatic urothelial cancer. Early clinical trials identified blurry vision, increased lacrimation and other events associated wit...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493475/ https://www.ncbi.nlm.nih.gov/pubmed/34629907 http://dx.doi.org/10.2147/IMCRJ.S324394 |